Lilly Announces Mfg Expansions in Ireland Totaling $1.8 Bn 
By

By
Eli Lilly and Company has announced a pair of manufacturing expansions in Ireland, totaling $1.8 billion. The company announced a $1-billion expansion of its Limerick, Ireland, site to increase production…

Roche Opens New $1.4-Bn R&D Center 
By

By
Roche has opened a new CHF 1.2-billion ($1.4 billion) pharma research and early development center at its global headquarters in Basel, Switzerland.   The center houses approximately 1,000 laboratory and office…

Sanofi Completes Construction of New $554-M Vaccine & Biomedicine Facility 
By

By
Sanofi has inaugurated a new EUR 500-million ($554-million) modular vaccines and biomedicines production unit, called Modulus, in Neuville-sur-Saône, Lyon, France.  Modulus can manufacture up to four vaccines or biomedicines simultaneously…

Supplier News: PanTera, MilliporeSigma, Evonik & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring PanTera, MilliporeSigma, Evonik, Seran Biosciences, Cellular Origins and 3P innovation.   Chemicals/Chemical API Manufacturing * Radioisotope Company PanTera Raises $102 M To Fund Mfg…

Pfizer, Moderna Get FDA OK for Updated COVID Vaccines 
By

By
The US Food and Drug Administration (FDA) has granted approval to Pfizer/BioNTech and Moderna for their respective supplemental biologics license applications for their updated mRNA COVID-19 vaccines, tailored to the…

Endo’s CEO Departs; Names Interim CEO 
By

By
The Board of Director of Endo, a specialty pharma and generics company, reports that the company’s President and CEO, Blaise Coleman, departed the company, effective August 29, 2024, and that…

Supplier News: Bora, Recipharm, Olon & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Bora Pharmaceuticals, Recipharm, Olon, Evotec, Renaissance Lakewood, Aenova, Rentschler Biopharma, Vetter, and Cardinal Health.   Chemicals/Chemical API Manufacturing * Olon Acquires API & Intermediates…

Mfg News: Novartis, Lilly & EVA Pharma 
By

By
A roundup of manufacturing news from Novartis, Eli Lilly and Company/EVA Pharma. Highlights below.  * Novartis Begins Construction of Two New Radiopharma Facilities in the US * Lilly, Egypt’s EVA Pharma in…

Partnering News: Lilly, Novartis, Pfizer & More 
By

By
A roundup of bio/pharmaceutical partnering news from Eli Lilly and Company/Haya Therapeutics, Novartis/Lindy Biosciences and Pfizer/Flagship Pioneering/Quotient Therapeutics.  * Lilly, Haya Theraepeutics in $1-Bn Deal for RNA-Based Drug Discovery for…

Global Briefs: UCB, BioMarin & Emergent 
By

By
A roundup of news from UCB, BioMarin and Emergent BioSolutions. Highlights below.   M&A News * UCB To Divest Neurology & Allergy Business in China for $680 M   General * BioMarin Plans to…